Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

A post-COVID-19 patient in Manaus developed cryptococcal meningitis, highlighting the need for better health education and sanitation.

Multiomics is revolutionizing biology by enabling breakthroughs in research and disease diagnosis.

COVID-19 can cause hair loss and nail changes in some patients.

A new change in the WNT10A gene caused a condition leading to short hair growth in a Chinese family.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Complete COVID-19 vaccination reduces the risk of long COVID.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.